九五至尊网址

九五至尊网址Akeso, Inc. (9926.HK) is a biopharmaceutical company dedicated to the research, development, manufacturing and commercialization of new innovative antibody drugs that are affordable to patients worldwide.

Since our establishment, the Company has established an comprehensive in-house drug development platform (ACE Platform), encompassing fully integrated drug discovery and development functions, including target validation, antibody drug discovery and development, process development, and GMP-compliant commercial scale manufacturing. The Company has also successfully established a bi-specific antibody drug development technology platform (Tetrabody Technology Platform). The Company currently has a pipeline of over 20 innovative investigative drugs for the treatment of major diseases like cancer  and autoimmune diseases, 12(including 3 out licensed) of which have entered clinical stage, including two first-in-class bi-specific antibody drugs (PD-1/CTLA-4 and PD-1/VEGF). The Company’s vision is to become a global leading biopharmaceutical company through research and development of break-through new drugs that are first-in-class and best-in-class therapies.

In oncology therapeutic area, the products in advanced development include an anti-PD-1/CTLA-4 bi-specific antibody (AK104), an anti-PD-1 antibody (penpulimab (AK105)) , and AK112, a potential first-in-class PD-1/VEGF bi-specific antibody. In immunology therapeutic area, the Company has built one of the richest pipeline targeting autoimmune diseases among China-based biotech companies. Our product candidates in this area include anti-IL12/IL23 monospecific antibody (AK101), an anti-IL17 monospecific antibody (AK111), one drug candidate with IND approved in Australia (AK120, an IL-4R antibody), and one more in IND-enabling stage (AK114, an IL-1 beta antibody.

www.782.net-最新网址-九五至尊网址 8455娱乐场门新葡8455最新网站-九五至尊网址 357 cc拉斯维加斯3499-九五至尊网址 澳门新莆京98378com-九五至尊网址 澳门太阳集团2007登陆注册-九五至尊网址 新葡京集团 www.350.vip-九五至尊网址 永利402com官方网站手机版-九五至尊网址 澳门新葡亰平台游戏app官网九五至尊网址-九五至尊网址 95992222九五至尊老品牌-九五至尊网址 mg4155娱乐电子游戏官网-九五至尊网址 伟德betvictot手机版-九五至尊网址 188金宝搏亚洲体育app下载-九五至尊网址 vnsc5858威尼斯城官网-九五至尊网址 188金宝搏亚洲体育app-九五至尊网址 澳门威尼斯人官方网投电子游戏-九五至尊网址 js55658澳门金金沙平台-九五至尊网址 亚洲城vipca88手机版登陆-九五至尊网址 williamhill-九五至尊网址 澳门新葡350vip最新网站-九五至尊网址 95998888九五至尊在线-九五至尊网址